mitogen-activated protein kinase 3
MAPK3 (mitogen-activated protein kinase 3) is targeted by 153 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 153 compounds. Use the BiohacksAI search to explore all MAPK3 modulators.
MAPK3 (mitogen-activated protein kinase 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 153 compounds with documented MAPK3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
MAPK3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.